Polaryx Therapeutics, Inc. Common Stock PLYX · SEC Filings

website

Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule t...

Price1.94

Market Cap96.7 M

Float18.98 M

CountryUS

SectorHealthcare

ExchangeNASDAQ

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

TYPE

HEADLINE

FILED AT

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 23, 2026

News

TYPE

HEADLINE

FILED AT

8-K

Polaryx Therapeutics, Inc. Announces Voting Results from its 2026 Annual Meeting of Stockholders

Sep 11, 2026

8-K

Polaryx Therapeutics Appoints Will Charlton, M.D., M.A.S. as Chief Medical Officer

Sep 1, 2026

8-K

Polaryx Therapeutics Announces Resignation of Chief Medical Officer

Jul 21, 2026

8-K

Polaryx Therapeutics, Inc. Announces 2026 Annual Meeting of Stockholders

Jul 17, 2026

8-K

Polaryx Therapeutics Announces Closing of $10 Million Private Placement Equity Financing to Support Launch of SOTERIA Phase 2 Basket Trial

May 28, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B4

SHARE RESALE REGISTRATION | Shares: 47,343,297 | Bank: Maxim Group LLC

Feb 2, 2026

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 24, 2026

8-A12B

Form 8-A12B - Registration of securities [Section 12(b)]

Jan 27, 2026

S-1/A

SHARE RESALE REGISTRATION | Shares: 47,343,297

Jan 27, 2026

S-1/A

SHARE RESALE REGISTRATION

Jan 13, 2026

S-1

SHARE RESALE REGISTRATION

Nov 20, 2025

DRS/A

Form DRS/A - Draft Registration Statement: [Amend]

Sep 18, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Jul 28, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Jul 28, 2026

Ownerships

TYPE

HEADLINE

FILED AT

Yang Alex Keun Mo (Reporting)

May 28, 2026

Landis G. Michael (Reporting)

Feb 20, 2026

SCHEDULE 13D

Mstone Partners Healthcare Ltd (Filed by)

Feb 5, 2026

Yang Alex Keun Mo (Reporting)

Jan 29, 2026

Braun III Francis A (Reporting)

Jan 29, 2026

Bollinger Lisa (Reporting)

Jan 29, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Jan 30, 2026